Stephen McIlhenny, PhD, MBA, is currently the Vice President of Project and Portfolio Management at Madrigal Pharmaceuticals, a position they have held since 2025. They previously served in various roles, including Vice President at Spark Therapeutics, where they led Corporate Strategy and Operations until 2025. Earlier in their career, Stephen worked at Stryker Orthobiologics as a Manager in Technology and Innovation and Research. They earned a PhD from Thomas Jefferson University and an MBA from The Wharton School, further enhancing their expertise in project management and strategy in the life sciences sector.
Location
Philadelphia, United States
This person is not in any offices